Peregrine Pharmaceuticals Inc. Fund Predictions

NASDAQ Stock Exchange

Open Broker Account

$4.22

+0 (+0%)

At Close: Jan 22, 2018

Currently predicting for Mon, 13 May 2024

Trading levels for PPHM

Fibonacci Support & Resistance Levels

		Level	Price
	Resistance	R3	4.22	.
		R2	4.22	.
		R1	4.22	.
Current price:			4.22
	Support	S1	4.22	.
		S2	4.22	.
		S3	4.22	.

Accumulated Volume Support & Resistance Levels

		Level	Price
	Resistance	R3	4.56	8.06 %
		R2	4.35	3.08 %
		R1	4.27	1.18 %
Current price			4.22
	Support	S1	4.20	-0.474%
		S2	4.11	-2.61%
		S3	4.02	-4.74%

PPHM Predictions History

7 years ago
Chris.Ruel.10 predicted that PPHM for 2016-05-23 is going $0.98 (-64.10%)

Rank:

About Peregrine Pharmaceuticals Inc.

Peregrine Pharmaceuticals, Inc., a biopharmaceutical company, researches and develops monoclonal antibodies for the treatment of cancer in the United States. Its lead immunotherapy candidate bavituximab, a monoclonal antibody that targets and binds to phosphatidylserine. The company also provides integrated current good manufacturing practices services from cell line development to commercial bio manufacturing for its third-party customers. In ... PPHM Profile

Golden Star

Ticker	Date	Change	Price
SXI	May 08	2.97%	$173.34
NVO	May 08	1.37%	$126.69
PAG	May 07	1.42%	$153.22
WMT	May 06	1.02%	$59.87
UNP	May 06	3.42%	$239.21
JPM	May 06	3.53%	$192.00
INGR	May 03	4.94%	$114.56
ASH	May 03	2.28%	$95.85
INVH	May 03	1.13%	$34.39
INTU	May 03	0.483%	$629.27

Unlock

Top Fintech Company

featured in The Global Fintech Index 2020 as the top Fintech company of the country.

Full report by

Sign In